CIPLA
vs
ZYDUSLIFE
CIPLA
ZYDUSLIFE
Over the past 12 months, CIPLA has underperformed ZYDUSLIFE, delivering a return of -18% compared to the ZYDUSLIFE's +11% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
CIPLA
ZYDUSLIFE
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Cipla Ltd
NSE:CIPLA
|
1 237.2
INR
|
|||||
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
937.9
INR
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
CIPLA, ZYDUSLIFE
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
|
Cipla Ltd
Revenue
|
|||||||||||
|
|
Zydus Lifesciences Ltd
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
CIPLA, ZYDUSLIFE
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
|
Cipla Ltd
NSE:CIPLA
|
|||||||||
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
|||||||||
Compare company's free cash flow with its competitors.
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Cipla Ltd | ||||
|
|
Zydus Lifesciences Ltd | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
CIPLA, ZYDUSLIFE
Performance Gap
CIPLA, ZYDUSLIFE
Performance By Year
CIPLA, ZYDUSLIFE
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Eli Lilly and Co
NYSE:LLY
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
